Results 21 to 30 of about 137,221 (325)

Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2023
The clinical management of placenta accreta spectrum (PAS) depends on placental topography and vascular involvement. Our aim was to determine whether transabdominal and transvaginal ultrasound signs can predict PAS management.
R. Aryananda   +5 more
semanticscholar   +1 more source

Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta‐analysis

open access: yesUltrasound in Obstetrics and Gynecology, 2023
To report on the occurrence of urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders (PAS).
Jauniaux Eric Orcid   +11 more
semanticscholar   +1 more source

Cesarean scar defects and placental abnormalities – a 3 year survey study [PDF]

open access: yes, 2017
The placenta is an essential organ for embryonic and fetal development, ensuring nutrient uptake, gas exchange (via the mother\u27s blood supply), waste elimination, thermo-regulation, immunological and hormonal factors, etc.
Bacalbașa, Nicolae   +2 more
core   +8 more sources

A comparison of results following the treatment of placenta accreta and placenta increta using high-intensity focused ultrasound followed by hysteroscopic resection

open access: yesInternational Journal of Hyperthermia, 2021
Objective To compare the safety and efficacy of high-intensity focused ultrasound (HIFU) followed by hysteroscopic resection for different placenta accreta spectrum disorders.
Zhenjiang Lin   +13 more
doaj   +1 more source

Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum

open access: yesBMC Pregnancy and Childbirth, 2023
Background To develop an ultrasound scoring system for placenta accreta spectrum (PAS), evaluate its diagnostic value, and provide a practical approach to prenatal diagnosis of PAS.
Junling Zhang   +5 more
semanticscholar   +1 more source

Identification of altered miRNAs and their targets in placenta accreta

open access: yesFrontiers in Endocrinology, 2023
Placenta accreta spectrum (PAS) is one of the major causes of maternal morbidity and mortality worldwide with increasing incidence. PAS refers to a group of pathological conditions ranging from the abnormal attachment of the placenta to the uterus wall ...
J. Murrieta-Coxca   +9 more
semanticscholar   +1 more source

Placenta Accreta Overlying a Caesarean Section Scar: A 10-Year Experience in a Tertiary-Care Centre in Portugal

open access: yesActa Médica Portuguesa, 2021
Introduction: Placenta accreta spectrum disorders are among the leading causes of maternal morbidity and mortality and their prevalence is likely to increase in the future.
Margarida Cal   +3 more
doaj   +1 more source

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa

open access: yesAnnals of Medicine, 2021
This study was designed to explore the expression and the diagnostic value of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in pernicious placenta previa (PPP) combined placental accreta/increta. A total of 140
Na Wang, Dandan Shi, Na Li, Hongyuan Qi
doaj   +1 more source

Radiomics-based prediction of FIGO grade for placenta accreta spectrum

open access: yesEuropean Radiology Experimental, 2023
Background Placenta accreta spectrum (PAS) is a rare, life-threatening complication of pregnancy. Predicting PAS severity is critical to individualise care planning for the birth.
H. Bartels   +12 more
semanticscholar   +1 more source

Placenta accreta index as a predictor of placental invasion in cases of placenta previa

open access: yesJournal of Medicine in Scientific Research, 2022
Objective This study aims to evaluate the role of the placenta accreta index in predicting placental invasion in patients with placenta previa. Patients and methods This study was carried on 60 pregnant women with placenta previa (after 30 weeks ...
Ibrahim M El-Maghraby, Ahmed A Badr
doaj   +1 more source

Home - About - Disclaimer - Privacy